Charles River Laboratories In Collaboration With MatTek Awarded $1.3M Grant From The Foundation For Chemistry Research And Initiatives To Advance Research Alternatives
Portfolio Pulse from Benzinga Newsdesk
Charles River Laboratories International, Inc. (NYSE:CRL) has been awarded a $1.3 million grant from the Foundation for Chemistry Research & Initiatives to develop an in vitro alternative to inhalation toxicology studies. The project is a collaboration with MatTek Corporation and other partners, aiming to reduce reliance on traditional animal research methods.
June 11, 2024 | 12:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Charles River Laboratories International, Inc. (NYSE:CRL) has received a $1.3 million grant to develop an in vitro alternative to inhalation toxicology studies, in collaboration with MatTek Corporation and other partners. This initiative aims to reduce the use of animals in research.
The grant and collaboration highlight CRL's commitment to innovative research methods and reducing animal testing, which could positively impact its reputation and future business opportunities.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100